Crinetics Pharmaceuticals Inc (CRNX)
50.75
+0.17
(+0.34%)
USD |
NASDAQ |
Sep 27, 16:00
50.72
-0.03
(-0.06%)
After-Hours: 20:00
Crinetics Pharmaceuticals Free Cash Flow: -185.05M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
June 30, 2024 | -185.05M |
March 31, 2024 | -184.45M |
December 31, 2023 | -171.00M |
September 30, 2023 | -167.03M |
June 30, 2023 | -161.35M |
March 31, 2023 | -143.96M |
December 31, 2022 | -116.86M |
September 30, 2022 | -104.30M |
June 30, 2022 | -90.95M |
March 31, 2022 | -82.47M |
December 31, 2021 | -89.02M |
September 30, 2021 | -82.06M |
June 30, 2021 | -74.35M |
March 31, 2021 | -70.11M |
Date | Value |
---|---|
December 31, 2020 | -62.21M |
September 30, 2020 | -59.73M |
June 30, 2020 | -55.24M |
March 31, 2020 | -52.00M |
December 31, 2019 | -46.87M |
September 30, 2019 | -39.69M |
June 30, 2019 | -32.03M |
March 31, 2019 | -24.22M |
December 31, 2018 | -20.52M |
September 30, 2018 | -16.97M |
June 30, 2018 | -13.49M |
March 31, 2018 | -10.90M |
December 31, 2017 | -9.783M |
Free Cash Flow Range, Past 5 Years
-185.05M
Minimum
Jun 2024
-39.69M
Maximum
Sep 2019
-101.93M
Average
-85.75M
Median
Free Cash Flow Benchmarks
PTC Therapeutics Inc | -230.14M |
Zevra Therapeutics Inc | -56.06M |
NovaBay Pharmaceuticals Inc | -3.396M |
Palatin Technologies Inc | -33.83M |
iBio Inc | -18.55M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -45.62M |
Cash from Investing (Quarterly) | -53.64M |
Cash from Financing (Quarterly) | 5.496M |
Free Cash Flow Per Share (Quarterly) | -0.5895 |
Free Cash Flow to Equity (Quarterly) | -46.57M |
Free Cash Flow Yield | -5.30% |